Women's Health Emerges as Global Priority as H&H Group Invests in Real-World Evidence

A billion women crossed into menopause in 2025. That's roughly one in eight people on the planet entering a life stage that, for many, arrives without adequate preparation, understanding, or support. In Australia alone, the numbers tell a story of widespread struggle: nine in ten women experience severe period pain, and four in ten lose workdays because of it. When menopause arrives, the disruption deepens—one in six women aged 45 to 55 need extended leave from work to manage their symptoms. These are not edge cases. They are the ordinary experience of ordinary women, and they carry real economic weight.

What makes this particularly striking is the knowledge gap. Four in ten Australian women don't understand what's happening in their bodies during perimenopause or menopause, even as these transitions reshape their lives. Yet there's a clear preference among women for vitamins, minerals, and supplements over prescription medicines or hormone replacement therapy. The disconnect is real: women want solutions, but they lack the information to make informed choices. This matters beyond individual health. Women control roughly eighty percent of healthcare spending globally. When women suffer, when they're confused, when they're absent from work—the ripple extends through families and economies.

The conversation is shifting. In 2025, Australia's government declared women's health a national priority, a recognition that came after years of underfunding and public pressure. Younger generations of women are speaking openly about their experiences. Social media and mainstream outlets are normalizing discussions that were once whispered or hidden. Dr. Novita Puspasari, Scientific Affairs Manager at H&H Group, framed it plainly at the Growth Asia Summit in 2026: closing the gap in women's health means 3.9 billion women could live healthier lives, which translates to measurable gains in global economic output. This isn't sentimentality. It's arithmetic.

The destigmatization is doing real work. These conversations educate the public about what's normal and what isn't. They dismantle barriers that have stood for generations. Yet the demand for credible, science-backed solutions is outpacing supply. H&H Group commissioned research involving 778 Australian women to understand what they actually want. One in three said they'd consider purchasing women's health supplements. Women were nearly three times more likely than men to recognize the value of supplements for hormonal balance. The strongest interest came from women aged 35 to 54—the years when perimenopause and menopause typically arrive.

To meet this demand responsibly, H&H Group is investing in real-world evidence research. This is different from traditional clinical trials. While randomized controlled trials remain the gold standard for proving efficacy, they often exclude the very people who will actually use the products—they're too strict, too controlled. Real-world evidence captures what happens when products enter everyday life: how diverse populations use them, whether they work as promised, how they affect quality of life and mental well-being. It's the difference between a laboratory and a living room. The data comes from disease registries, electronic health records, wearables, mobile apps, and observational studies. It's continuous feedback, not a one-time verdict.

This approach allows companies to understand not just whether a product works, but why it works, for whom, and what consumers actually feel. It creates a feedback loop that informs product development and marketing. Dr. Puspasari noted that this could drive product differentiation through credible evidence and help educate consumers about benefits that go beyond what's printed on packaging. Women's health, she emphasized, extends far beyond period pain and menopause. It spans every stage of life and every dimension of well-being.

There's a historical shadow here worth naming. Before 1993, including women in medical research wasn't mandatory. That decades-long gap in evidence has consequences that persist today. The way forward requires innovation that evolves alongside emerging research, and it requires brands to deliver reliable, evidence-backed content while fighting the spread of misinformation. H&H Group frames itself as early in this work, only beginning to unlock what's possible. The demand is there. The government support is there. The conversation has opened. What remains is the unglamorous work of building solutions that women can trust.